MannKind Corporation develops patient-focused drug therapies and innovative technology solutions.
We specialize in innovative technologies with proven ease-of-use and patient acceptance.
Needle-free, self-administered Inhalation Treatment Systems for both chronic and acute diseases.
Our Technosphere® technology can accommodate a wide variety of APIs required by specific drug therapies.
MannKind Corporation (NASDAQ and TASE: MNKD) is a biopharmaceutical company that focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes. More
|Jul 17, 2017||Steven Binder Joins MannKind as Chief Financial Officer … More|
|Jul 12, 2017||Patrick McCauley Joins MannKind as Chief Commercial Officer… More|
|Jun 29, 2017||MannKind Renegotiates Near-Term Maturities with Deerfield… More|